Description: With more than 24 years of experience in the reinsurance market, Bruno Freire is the CEO and one of the co-founders of Austral Re, along with Vinci Partners, a private equity firm. Austral Re is a Brazilian- based multiline reinsurer which that writes business across Latin America. It has grown organically throughout the last 13 years, and had its credit rating upgraded to A- in 2023 by AM Best (it also has AAAbr from S&P). Before joining Austral, Bruno had been a reinsurance broker at Aon Re for more than 10 years, having witnessed the opening of the reinsurance market in Brazil. As we will be seen in his interview the following, he believes in a data driven analytic approach, client focused but with an underwriting mindset, as well as a strong support from actuaries and technology as key instruments to run a reinsurance company successfully.

Description: Exploration of the relationship between insuretech and reinsurance in Life and P&C

Description: Re/insurance rates have been increasing since 2018, although pricing momentum has decelerated recently. Insurers and reinsurers are working to enhance profitability and improve the value proposition for clients in an environment of uncertainty about natural catastrophes, COVID-19-related losses, and social inflation, among other factors. This article describes drivers of the current underwriting cycle, compares it with past cycles, and provides considerations for the future.

Description: Cell and Gene Therapy (CGT) are life-changing treatments where conditions such as cancer, hemophilia, spinal muscular atrophy and blindness are being cured. These are great for individuals and society, but the treatment costs are expensive which is bad for payers and reinsurers. This article explores ways for health reinsurance actuaries to participate in the space and evaluate the risk associated with these treatments

Description: Article about talent crisis in insurance industry

Description: To understand the relationship between lifestyle behaviors and mortality, RGA investigated a national, health-related, mortality-linked data set provided by the U.S. Centers for Disease Control and Prevention (CDC). RGA Strategic Research Actuary Julianne Callaway discusses the company's findings.

Description: The life insurance industry has experienced dramatic changes since the onset of COVID-19 in March 2020. Growing competition, a rise in online shopping, and the impact of COVID-19 have all led to an increase in contactless and completely digitized life insurance options. At Policygenius, we wanted to dig deeper into these big industry changes and better understand how they affect life insurance buyers. What our 2022 life insurance trend report found was a changing industry, making tremendous strides, and creating even better pricing and policy options for customers.

Description: Highlights the key takeaways from the 2021 published SOA PLT study on lapse and mortality experience of US term plans in the post level term period. This article explains the new insights in the latest study including a comparison of PLT experience between Jump to ART and Graded structures. The important variables driving PLT experience and the relationship between lapse and mortality experience are also discussed.

Description: The article summarizes the results of the 2022 U.S. and Canadian Life Reinsurance Survey, for both Individual Life and Group Life business, conducted by the Reinsurance Section of the Society of Actuaries.

Description: The article examines the impact of the COVID-19 pandemic on U.S. mortality trends, noting that despite a decrease in COVID-19 deaths due to better treatments and vaccinations, excess mortality persists, especially among younger adults due to accidental causes. It discusses the challenges of predicting future mortality trends, considering factors like medical advancements and societal changes. The article also highlights the potential of new medical technologies and AI to significantly improve health outcomes in the future. Overall, it underscores the complex interplay of various factors influencing mortality in the post-pandemic era.